Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

LIXTE Biotechnology Announces Presentation Of Pre-Clinical Data On LIXTE's LB-100 At Joint Conference Of European And American Associations for Cancer Research

Author: Benzinga Newsdesk | February 27, 2024 09:36am

Conference In Dublin, Ireland on February 27 - 29, 2024

Focuses on How to Bring Basic Science Discoveries to the Clinic

Posted In: LIXT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist